Found 11 results
Author Title Type [ Year(Asc)]
Filters: Author is Nussenblatt, RB  [Clear All Filters]
2009
H. Sen, Levy-Clarke, G., Faia, L. J., Zhuqing, L., Barron, K. S., Hammel, K., and Nussenblatt, R. B., “Association for Research in Vision and Ophthalmology”, presented at the 2009, Ft. Lauderdale FL, 2009.
H. N. Sen, Sangave, A., Hammel, K., Levy-Clarke, G., and Nussenblatt, R. B., “Infliximab for the Treatment of Active Scleritis”, Can J Ophthalmol, vol. 44, pp. e9-e12, 2009.
2007
R. R. Buggage, Levy-Clarke, G., Sen, H. N., Ursea, R., Srivastava, S. K., Suhler, E. B., Alternare, C., Velez, G., Ragheb, J., Chan, C., Nussenblatt, R. B., Bamji, A. T., Sran, P., Waldmann, T., and Thompson, D., “A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease”, Ocul Immunol Inflamm, vol. 15, pp. 63-70, 2007.
2006
R. B. Nussenblatt, Kim, J., Thompson, D. J. S., Davis, M. D., Chew, E., Ferris, F. L., and Buggage, R. R., “Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema”, Am J Ophthalmol, vol. 141, pp. 193-194, 2006.
2005
R. B. Nussenblatt, Peterson, J. S., Foster, C. S., Rao, N. A., See, R. F., Letko, E., and Buggage, R. R., “Initial Evaluation of Subcutaneous Daclizumab Treatments for Noninfectious Uveitis: A Multicenter Noncomparative Interventional Case Series”, Ophthalmology, vol. 112, pp. 764-770, 2005.
2004
R. B. Nussenblatt, Rao, N., Foster, C. S., Sen, H. N., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Shames, R. S., and Buggage, R. R., “Uveitis therapy: a phase II study using subcutaneously administered daclizumab”, 2004.
2003
R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. T., Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. N., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., and , “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration”, J Autoimmun, vol. 21, pp. 283-293, 2003.
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., “Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis”, 2003.
2000
R. B. Nussenblatt, Fortin, E., Schiffman, R., Risso, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “The use of monoclonal therapy in the treatment of intraocular inflammatory disease”, 2000.
1999
S. M. Whitcup, Fortin, E., Lindblad, A. S., Griffiths, P., Metcalf, J. A., Robinson, M. R., Manischewitz, J., Baird, B., Perry, C., Kidd, I. M., Vrabec, T., Davey, R. T., Falloon, J., Walker, R. E., Kovacs, J. A., Lane, H. C., Nussenblatt, R. B., Smith, J., Masur, H., and Polis, M. A., “Discontinuation of Anticytomegalovirus Therapy in Patients with HIV Infection and Cytomegalovirus Retinitis”, JAMA, vol. 282, no. 17, pp. 1633-1637, 1999.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., “Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial”, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.